Previous close | 48.54 |
Open | 49.03 |
Bid | 48.42 x 300 |
Ask | 48.60 x 100 |
Day's range | 47.90 - 49.28 |
52-week range | 16.96 - 73.00 |
Volume | |
Avg. volume | 392,141 |
Market cap | 1.331B |
Beta (5Y monthly) | 1.25 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.07 |
Earnings date | 08 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 60.33 |
NEW YORK, April 24, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2024 after the market closes on Wednesday, May 8, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results.
NEW YORK, April 17, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in The Aesthetic Meeting 2024, which is being held May 2-5 in Vancouver, BC Canada.
Shareholders of Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) will be pleased this week, given that the stock price...